Applied Therapeutics, Inc. Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)… Read More
Zeta Global Holdings Corp. Deadline to Lead in Securities Fraud Lawsuit against Zeta Global Holdings Corp. (ZETA) is January 21, 2025 – Contact Kaplan Fox & Kilsheimer LLP… Read MoreJoin Investigation
Macy’s, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Macy’s, Inc. (M) for Potential Securities Law Violations… Read MoreJoin Investigation
Quanterix Corp Kaplan Fox & Kilsheimer LLP is Investigating Quanterix Corp (QTRX) for Potential Securities Law Violations… Read MoreJoin Investigation
Humacyte, Inc. HUMA Deadline to Lead in Securities Fraud Lawsuit is January 17, 2025 – Contact Kaplan Fox & Kilsheimer LLP… Read MoreJoin Investigation
Edwards Lifesciences Corporation Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities between February 6, 2024 and July 24, 2024 (the “Class Period”)…. Read MoreJoin Investigation
United Parcel Service, Inc. Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against United Parcel Service, Inc. (“UPS” or the “Company”) (NYSE: UPS) securities between January 30, 2024 and July 22, 2024 (the “Class Period”)…. Read MoreJoin Investigation
Elanco Animal Health Incorporated Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) securities between November 7, 2023 and June 26, 2024 (the “Class Period”)…. Read MoreJoin Investigation
